Exact Mass: 846.3885101999999

Exact Mass Matches: 846.3885101999999

Found 44 metabolites which its exact mass value is equals to given mass value 846.3885101999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sucrose acetate isobutyrate

[(2R,3R,4S,5S)-5-[(Acetyloxy)methyl]-5-{[(2R,3R,4S,5R,6R)-6-[(acetyloxy)methyl]-3,4,5-tris[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-3,4-bis[(2-methylpropanoyl)oxy]oxolan-2-yl]methyl 2-methylpropanoic acid

C40H62O19 (846.3885101999999)


Clouding agent, stabiliser and specific gravity control agent for beverages, especially fruit drinks Sucrose acetoisobutyrate (SAIB) is a emulsifier and has E Number E444. Clouding agent, stabiliser and specific gravity control agent for beverages, especies fruit drinks

   

PGP(i-12:0/PGF1alpha)

[(2S)-3-({[(2R)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoyl}oxy)-3-[(10-methylundecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy]phosphonic acid

C38H72O16P2 (846.4295372)


PGP(i-12:0/PGF1alpha) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(i-12:0/PGF1alpha), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of Prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PGP(PGF1alpha/i-12:0)

[(2S)-3-({[(2R)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoyl}oxy)-2-[(10-methylundecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy]phosphonic acid

C38H72O16P2 (846.4295372)


PGP(PGF1alpha/i-12:0) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(PGF1alpha/i-12:0), in particular, consists of one chain of one Prostaglandin F1alpha at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   
   
   
   

beta-Dihydro-entandrophragmin

beta-Dihydro-entandrophragmin

C43H58O17 (846.3673818)


   

3beta-(2-O-sulfo-alpha-L-arabinopyranosyl)-27-dihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranoside

3beta-(2-O-sulfo-alpha-L-arabinopyranosyl)-27-dihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranoside

C41H66O16S (846.4071356000001)


   

3-O-[alpha-L-arabinofuranosyl(1->3)]-6-O-sulfonyl-beta-D-glucopyranosyl pseudojujubogenin|bacopaside-XI

3-O-[alpha-L-arabinofuranosyl(1->3)]-6-O-sulfonyl-beta-D-glucopyranosyl pseudojujubogenin|bacopaside-XI

C41H66O16S (846.4071356000001)


   
   

Ala-Hyp-Ala-Asn-Ser-D-Val-Trp-Ser

Ala-Hyp-Ala-Asn-Ser-D-Val-Trp-Ser

C37H54N10O13 (846.3871634)


   

2alpha,3beta,16beta-trihydroxy-5alpha-pregn-20(21)-ene-carboxylic acid gamma-lactone 3-O-{O-beta-D-glucopyranosyl-(1->2)-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside}

2alpha,3beta,16beta-trihydroxy-5alpha-pregn-20(21)-ene-carboxylic acid gamma-lactone 3-O-{O-beta-D-glucopyranosyl-(1->2)-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside}

C40H62O19 (846.3885101999999)


   

SAIB 100S

[(2R,3R,4S,5S)-5-[(acetyloxy)methyl]-5-{[(2R,3R,4S,5R,6R)-6-[(acetyloxy)methyl]-3,4,5-tris[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-3,4-bis[(2-methylpropanoyl)oxy]oxolan-2-yl]methyl 2-methylpropanoate

C40H62O19 (846.3885101999999)


   

Monopotassium glycyrrhizinate

Monopotassium glycyrrhizinate

C42H63KO15 (846.3803828)


   

AC-SER-GLN-ASN-TYR-PRO-VAL-VAL-NH2

AC-SER-GLN-ASN-TYR-PRO-VAL-VAL-NH2

C38H58N10O12 (846.4235468)


   

Sucrose diacetate hexaisobutyrate

Sucrose diacetate hexaisobutyrate

C40H62O19 (846.3885101999999)


   
   
   

Euphorbiaproliferin B, (rel)-

Euphorbiaproliferin B, (rel)-

C46H54O15 (846.3462534)


A natural product found in Euphorbia prolifera.

   

[3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C45H67O13P (846.4319062)


   

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[hydroxy-[(5S)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[hydroxy-[(5S)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C45H67O13P (846.4319062)


   

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[hydroxy-[(5S)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[hydroxy-[(5S)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate

C45H67O13P (846.4319062)


   

Sucrose, diacetate hexaisobutyrate

Sucrose, diacetate hexaisobutyrate

C40H62O19 (846.3885101999999)


   

PIP(29:1)

PIP(20:1_9:0)

C38H72O16P2 (846.4295372)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   

[(2r,3r,4s,5r,6r)-4-{[(2s,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-{[(1s,2r,5r,7s,10r,11r,14r,15s,16s,17r,20r)-16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-2-yl]methoxysulfonic acid

[(2r,3r,4s,5r,6r)-4-{[(2s,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-{[(1s,2r,5r,7s,10r,11r,14r,15s,16s,17r,20r)-16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-2-yl]methoxysulfonic acid

C41H66O16S (846.4071356000001)


   

2,3-dihydroxy-23,24,25,26,27-pentanorcholest-20-en-22,16-olide; (2α,3β,16β)-form,3-o-[beta-d-glucopyranosyl-(1→2)-beta-d-glucopyranosyl-(1→4)-beta-d-galactopyranoside]

NA

C40H62O19 (846.3885101999999)


{"Ingredient_id": "HBIN004040","Ingredient_name": "2,3-dihydroxy-23,24,25,26,27-pentanorcholest-20-en-22,16-olide; (2\u03b1,3\u03b2,16\u03b2)-form,3-o-[beta-d-glucopyranosyl-(1\u21922)-beta-d-glucopyranosyl-(1\u21924)-beta-d-galactopyranoside]","Alias": "NA","Ingredient_formula": "C40H62O19","Ingredient_Smile": "NA","Ingredient_weight": "846.91","OB_score": "NA","CAS_id": "186901-40-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8940","PubChem_id": "NA","DrugBank_id": "NA"}

   

bacopaside iii

NA

C41H66O16S (846.4071356000001)


{"Ingredient_id": "HBIN017496","Ingredient_name": "bacopaside iii","Alias": "NA","Ingredient_formula": "C41H66O16S","Ingredient_Smile": "CC(=CC1COC23CC4(CO2)C(C3C1(C)O)CCC5C4(CCC6C5(CCC(C6(C)C)OC7C(C(C(CO7)O)OC8C(C(C(C(O8)COS(=O)(=O)O)O)O)O)O)C)C)C","Ingredient_weight": "847 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2088","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "15922618","DrugBank_id": "NA"}

   

[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4s,5s)-3,5-dihydroxy-2-{[(1s,2r,5r,7s,10r,11r,14r,15s,16s,17r,20r)-16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-4-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid

[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4s,5s)-3,5-dihydroxy-2-{[(1s,2r,5r,7s,10r,11r,14r,15s,16s,17r,20r)-16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-4-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid

C41H66O16S (846.4071356000001)


   

2-[(1-hydroxyethylidene)amino]-3-{[(7e,12e,16e,22e,24e,26z)-4,10,14,20,28-pentahydroxy-3,7,9,11,17,21,27-heptamethyl-6,18,32,34-tetraoxo-29-azatricyclo[28.3.1.0⁵,³³]tetratriaconta-1(33),2,4,7,12,16,22,24,26,28,30-undecaen-31-yl]sulfanyl}propanoic acid

2-[(1-hydroxyethylidene)amino]-3-{[(7e,12e,16e,22e,24e,26z)-4,10,14,20,28-pentahydroxy-3,7,9,11,17,21,27-heptamethyl-6,18,32,34-tetraoxo-29-azatricyclo[28.3.1.0⁵,³³]tetratriaconta-1(33),2,4,7,12,16,22,24,26,28,30-undecaen-31-yl]sulfanyl}propanoic acid

C45H54N2O12S (846.3397284000001)


   

(4-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-{[16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-2-yl)methoxysulfonic acid

(4-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-{[16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-2-yl)methoxysulfonic acid

C41H66O16S (846.4071356000001)


   

(1r,2s,4s,8s,9s,12s,13s,15r,16r,18s)-16-{[(2r,3r,4r,5r,6r)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-15-hydroxy-9,13-dimethyl-7-methylidene-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

(1r,2s,4s,8s,9s,12s,13s,15r,16r,18s)-16-{[(2r,3r,4r,5r,6r)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-15-hydroxy-9,13-dimethyl-7-methylidene-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

C40H62O19 (846.3885101999999)


   

3-[16-amino-3,6,9,12,15,27-hexahydroxy-10-(hydroxymethyl)-13-(2-methylpropyl)-4-octyl-19,21-dioxo-20-oxa-24,25-dithia-2,5,8,11,14,28-hexaazabicyclo[20.4.2]octacosa-2,5,8,11,14,27-hexaen-7-yl]-2-hydroxypropanimidic acid

3-[16-amino-3,6,9,12,15,27-hexahydroxy-10-(hydroxymethyl)-13-(2-methylpropyl)-4-octyl-19,21-dioxo-20-oxa-24,25-dithia-2,5,8,11,14,28-hexaazabicyclo[20.4.2]octacosa-2,5,8,11,14,27-hexaen-7-yl]-2-hydroxypropanimidic acid

C35H58N8O12S2 (846.3615428)


   

[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4s,5s)-3,5-dihydroxy-2-{[(1s,2r,5r,7s,10r,11r,14s,15s,16s,17r,20r)-16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-4-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid

[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4s,5s)-3,5-dihydroxy-2-{[(1s,2r,5r,7s,10r,11r,14s,15s,16s,17r,20r)-16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-4-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid

C41H66O16S (846.4071356000001)


   

{6-[(3,5-dihydroxy-2-{[16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-4-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methoxysulfonic acid

{6-[(3,5-dihydroxy-2-{[16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-4-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methoxysulfonic acid

C41H66O16S (846.4071356000001)


   

3-[(1r,4s,7s,10s,13s,16s,22r)-16-amino-3,6,9,12,15,27-hexahydroxy-10-(hydroxymethyl)-13-(2-methylpropyl)-4-octyl-19,21-dioxo-20-oxa-24,25-dithia-2,5,8,11,14,28-hexaazabicyclo[20.4.2]octacosa-2,5,8,11,14,27-hexaen-7-yl]-2-hydroxypropanimidic acid

3-[(1r,4s,7s,10s,13s,16s,22r)-16-amino-3,6,9,12,15,27-hexahydroxy-10-(hydroxymethyl)-13-(2-methylpropyl)-4-octyl-19,21-dioxo-20-oxa-24,25-dithia-2,5,8,11,14,28-hexaazabicyclo[20.4.2]octacosa-2,5,8,11,14,27-hexaen-7-yl]-2-hydroxypropanimidic acid

C35H58N8O12S2 (846.3615428)


   

(2r)-2-[(1-hydroxyethylidene)amino]-3-{[(7e,9s,10s,11s,12e,14s,16e,20s,21s,22e,24z,26z)-4,10,14,20,28-pentahydroxy-3,7,9,11,17,21,27-heptamethyl-6,18,32,34-tetraoxo-29-azatricyclo[28.3.1.0⁵,³³]tetratriaconta-1(33),2,4,7,12,16,22,24,26,28,30-undecaen-31-yl]sulfanyl}propanoic acid

(2r)-2-[(1-hydroxyethylidene)amino]-3-{[(7e,9s,10s,11s,12e,14s,16e,20s,21s,22e,24z,26z)-4,10,14,20,28-pentahydroxy-3,7,9,11,17,21,27-heptamethyl-6,18,32,34-tetraoxo-29-azatricyclo[28.3.1.0⁵,³³]tetratriaconta-1(33),2,4,7,12,16,22,24,26,28,30-undecaen-31-yl]sulfanyl}propanoic acid

C45H54N2O12S (846.3397284000001)


   

[(3r,4r,5r,6s)-6-{[(1s,2s,5r,6s,9s,10s,13s,16s,18r)-5,10-dihydroxy-2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-8-oxo-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-11-en-16-yl]oxy}-4-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

[(3r,4r,5r,6s)-6-{[(1s,2s,5r,6s,9s,10s,13s,16s,18r)-5,10-dihydroxy-2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-8-oxo-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-11-en-16-yl]oxy}-4-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

C41H66O16S (846.4071356000001)


   

16-[(5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-15-hydroxy-9,13-dimethyl-7-methylidene-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

16-[(5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-15-hydroxy-9,13-dimethyl-7-methylidene-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

C40H62O19 (846.3885101999999)